These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 24999245

  • 1. Multiple sclerosis patients lacking oligoclonal bands in the cerebrospinal fluid have less global and regional brain atrophy.
    Ferreira D, Voevodskaya O, Imrell K, Stawiarz L, Spulber G, Wahlund LO, Hillert J, Westman E, Karrenbauer VD.
    J Neuroimmunol; 2014 Sep 15; 274(1-2):149-54. PubMed ID: 24999245
    [Abstract] [Full Text] [Related]

  • 2. [Magnetic resonance findings in the brain of patients with multiple sclerosis without oligoclonal bands in the cerebrospinal fluid].
    Mesaroc S, Drulović J, Lević Z, Perić V.
    Srp Arh Celok Lek; 2003 Sep 15; 131(1-2):31-5. PubMed ID: 14608859
    [Abstract] [Full Text] [Related]

  • 3. CSF oligoclonal band status informs prognosis in multiple sclerosis: a case control study of 100 patients.
    Joseph FG, Hirst CL, Pickersgill TP, Ben-Shlomo Y, Robertson NP, Scolding NJ.
    J Neurol Neurosurg Psychiatry; 2009 Mar 15; 80(3):292-6. PubMed ID: 18829628
    [Abstract] [Full Text] [Related]

  • 4. Oligoclonal bands in the cerebrospinal fluid and increased brain atrophy in early stages of relapsing-remitting multiple sclerosis.
    Rojas JI, Patrucco L, Tizio S, Cristiano E.
    Arq Neuropsiquiatr; 2012 Aug 15; 70(8):574-7. PubMed ID: 22899026
    [Abstract] [Full Text] [Related]

  • 5. Cerebrospinal fluid oligoclonal bands and progression of disability in multiple sclerosis.
    Koch M, Heersema D, Mostert J, Teelken A, De Keyser J.
    Eur J Neurol; 2007 Jul 15; 14(7):797-800. PubMed ID: 17594338
    [Abstract] [Full Text] [Related]

  • 6. Oligoclonal bands and cerebrospinal fluid markers in multiple sclerosis: associations with disease course and progression.
    Lourenco P, Shirani A, Saeedi J, Oger J, Schreiber WE, Tremlett H.
    Mult Scler; 2013 Apr 15; 19(5):577-84. PubMed ID: 22961214
    [Abstract] [Full Text] [Related]

  • 7. Primary progressive versus relapsing-onset multiple sclerosis: presence and prognostic value of cerebrospinal fluid oligoclonal IgM.
    Sola P, Mandrioli J, Simone AM, Ferraro D, Bedin R, Annecca R, Venneri MG, Nichelli PF, Merelli E.
    Mult Scler; 2011 Mar 15; 17(3):303-11. PubMed ID: 21078694
    [Abstract] [Full Text] [Related]

  • 8. Intrathecal immunoglobulin G synthesis and brain injury by quantitative MRI in multiple sclerosis.
    Brandão CO, Ruocco HH, Farias AS, Oliveira C, Cendes F, Damasceno BP, Santos LM.
    Neuroimmunomodulation; 2006 Mar 15; 13(2):89-95. PubMed ID: 17033198
    [Abstract] [Full Text] [Related]

  • 9. Advanced MRI features in relapsing multiple sclerosis patients with and without CSF oligoclonal IgG bands.
    Zhao L, Abrigo J, Chen Q, Au C, Ng A, Fan P, Mok V, Qiu W, Kermode AG, Lau AY.
    Sci Rep; 2020 Aug 13; 10(1):13703. PubMed ID: 32792656
    [Abstract] [Full Text] [Related]

  • 10. White-matter lesions drive deep gray-matter atrophy in early multiple sclerosis: support from structural MRI.
    Mühlau M, Buck D, Förschler A, Boucard CC, Arsic M, Schmidt P, Gaser C, Berthele A, Hoshi M, Jochim A, Kronsbein H, Zimmer C, Hemmer B, Ilg R.
    Mult Scler; 2013 Oct 13; 19(11):1485-92. PubMed ID: 23462349
    [Abstract] [Full Text] [Related]

  • 11. Cerebrospinal fluid CXCL13 in multiple sclerosis: a suggestive prognostic marker for the disease course.
    Khademi M, Kockum I, Andersson ML, Iacobaeus E, Brundin L, Sellebjerg F, Hillert J, Piehl F, Olsson T.
    Mult Scler; 2011 Mar 13; 17(3):335-43. PubMed ID: 21135023
    [Abstract] [Full Text] [Related]

  • 12. Extent of cerebellum, subcortical and cortical atrophy in patients with MS: a case-control study.
    Ramasamy DP, Benedict RH, Cox JL, Fritz D, Abdelrahman N, Hussein S, Minagar A, Dwyer MG, Zivadinov R.
    J Neurol Sci; 2009 Jul 15; 282(1-2):47-54. PubMed ID: 19201003
    [Abstract] [Full Text] [Related]

  • 13. Gray matter atrophy in multiple sclerosis: a longitudinal study.
    Fisher E, Lee JC, Nakamura K, Rudick RA.
    Ann Neurol; 2008 Sep 15; 64(3):255-65. PubMed ID: 18661561
    [Abstract] [Full Text] [Related]

  • 14. Impact of cerebrospinal-fluid oligoclonal immunoglobulin bands and HLA-DRB1 risk alleles on brain magnetic-resonance-imaging lesion load in Swedish multiple sclerosis patients.
    Karrenbauer VD, Prejs R, Masterman T, Hillert J, Glaser A, Imrell K.
    J Neuroimmunol; 2013 Jan 15; 254(1-2):170-3. PubMed ID: 22967351
    [Abstract] [Full Text] [Related]

  • 15. Brain atrophy evolution and lesion load accrual in multiple sclerosis: a 2-year follow-up study.
    Tedeschi G, Dinacci D, Comerci M, Lavorgna L, Savettieri G, Quattrone A, Livrea P, Patti F, Morra VB, Servillo G, Orefice G, Paciello M, Prinster A, Coniglio G, Bonavita S, Di Costanzo A, Bellacosa A, Valentino P, Quarantelli M, Brunetti A, Salemi G, D'Amelio M, Simone I, Salvatore M, Bonavita V, Alfano B.
    Mult Scler; 2009 Feb 15; 15(2):204-11. PubMed ID: 18987104
    [Abstract] [Full Text] [Related]

  • 16. Brain volume in early MS patients with and without IgG oligoclonal bands in CSF.
    Fenu G, Lorefice L, Sechi V, Loi L, Contu F, Cabras F, Coghe G, Frau J, Secci MA, Melis C, Schirru L, Costa G, Melas V, Arru M, Barracciu MA, Marrosu MG, Cocco E.
    Mult Scler Relat Disord; 2018 Jan 15; 19():55-58. PubMed ID: 29132035
    [Abstract] [Full Text] [Related]

  • 17. Immunoglobulin M oligoclonal bands: biomarker of targetable inflammation in primary progressive multiple sclerosis.
    Villar LM, Casanova B, Ouamara N, Comabella M, Jalili F, Leppert D, de Andrés C, Izquierdo G, Arroyo R, Avşar T, Lapin SV, Johnson T, Montalbán X, Fernández O, Álvarez-Lafuente R, Masterman D, García-Sánchez MI, Coret F, Siva A, Evdoshenko E, Álvarez-Cermeño JC, Bar-Or A.
    Ann Neurol; 2014 Aug 15; 76(2):231-40. PubMed ID: 24909126
    [Abstract] [Full Text] [Related]

  • 18. Baló's concentric sclerosis is immunologically distinct from multiple sclerosis: results from retrospective analysis of almost 150 lumbar punctures.
    Jarius S, Würthwein C, Behrens JR, Wanner J, Haas J, Paul F, Wildemann B.
    J Neuroinflammation; 2018 Jan 18; 15(1):22. PubMed ID: 29347989
    [Abstract] [Full Text] [Related]

  • 19. Multiple sclerosis with and without CSF bands: clinically indistinguishable but immunogenetically distinct.
    Imrell K, Landtblom AM, Hillert J, Masterman T.
    Neurology; 2006 Sep 26; 67(6):1062-4. PubMed ID: 17000979
    [Abstract] [Full Text] [Related]

  • 20. Brain atrophy in relapsing-remitting multiple sclerosis and secondary progressive multiple sclerosis: longitudinal quantitative analysis.
    Ge Y, Grossman RI, Udupa JK, Wei L, Mannon LJ, Polansky M, Kolson DL.
    Radiology; 2000 Mar 26; 214(3):665-70. PubMed ID: 10715027
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.